| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 02/13/2001 | US6187777 Pyrrolo(3,2-d)pyrimidine derivatives; neuropeptide y and corticotropin releasing factor modulators; dietetics; antidiabetic, antiinflammatory, and antitumor agents |
| 02/13/2001 | US6187774 Fused heterocyclic compounds and pharmaceutical applications thereof |
| 02/08/2001 | WO2001055118A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient |
| 02/08/2001 | WO2001009372A1 Chemiluminescent substrates of hydrolytic enzymes such as phosphatases |
| 02/08/2001 | WO2001009139A1 Aromatic esters of camptothecins and methods to treat cancers |
| 02/08/2001 | WO2001009138A2 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | WO2001009137A1 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | WO2001009130A1 TRICYCLIC COMPOUNDS HAVING sPLA2-INHIBITORY ACTIVITIES |
| 02/08/2001 | WO2001009119A2 Chemokine receptor antagonists |
| 02/08/2001 | WO2001009101A1 Isoquinoline derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the active substance |
| 02/08/2001 | WO2001009094A2 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | WO2001009092A1 Biphenyl-substituted cyclic keto enols as pesticides |
| 02/08/2001 | WO2001008663A2 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| 02/08/2001 | WO2000076984A3 Novel compounds, their use and preparation |
| 02/08/2001 | CA2391267A1 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | CA2379660A1 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| 02/07/2001 | EP1073655A1 Pharmaceutically available protoberberine salts derivatives, and protoberberine derivatives and salts thereof |
| 02/07/2001 | EP1073654A1 2,3-olefinic epothilone derivatives |
| 02/07/2001 | EP1073648A1 12,13-Modified epothilone derivatives |
| 02/07/2001 | EP1073647A1 12,13-cyclopropane epothilone derivatives |
| 02/07/2001 | EP1073639A1 Quinoline derivatives |
| 02/07/2001 | EP1073435A1 Substituted tricyclic pyrazole derivatives with protein kinase activity |
| 02/07/2001 | EP0799226B1 Tetracyclic spiro compounds, process for their preparation and their use as 5ht1d receptor antagonists |
| 02/07/2001 | CN1283187A Novel dipydropyridine derivative |
| 02/07/2001 | CN1282517A Pest controlling agent containing substituted aminoquinazolone or thioketone derivative or its salt as active component |
| 02/07/2001 | CN1061658C Tricyclic benzazepine vasopression antagonists |
| 02/06/2001 | US6184379 Rhodamine derivatives and the use thereof |
| 02/06/2001 | US6184221 Antiarrhythmia agents, antiulcer agents |
| 02/06/2001 | US6184004 Process for the preparation of galanthamine and its derivatives |
| 02/01/2001 | WO2001007050A1 Nociceptin receptor orl-1 agonists for use in treating cough |
| 02/01/2001 | DE19935963A1 Biphenylsubstituierte cyclische Ketoenole Biphenyl-cyclic ketoenols |
| 02/01/2001 | CA2379398A1 Nociceptin receptor orl-1 agonists for use in treating cough |
| 01/31/2001 | EP1072593A1 Liquid crystalline compound having piperidine ring, liquid crystal composition and liquid crystal display element |
| 01/31/2001 | EP1071683A1 New compounds |
| 01/31/2001 | EP1071666A1 Azacycloalkane derivatives, preparation and therapeutic application |
| 01/31/2001 | EP1071455A1 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 01/31/2001 | EP0746320B1 Hiv protease inhibitors and intermediates |
| 01/31/2001 | CN1282332A Novel acronycine compounds, preparation method and pharmaceutical compositions containing them |
| 01/31/2001 | CN1061346C Diazabicycloalkene derivatives and use, and drug composition containing said derivatives |
| 01/30/2001 | US6180794 Steroids and dehydrohalogenation and amination |
| 01/30/2001 | US6180640 Di- and tetra-hydroquinoline-indole antimicrobial agents, uses and compositions related thereto |
| 01/25/2001 | WO2001005795A1 Remedies or preventives for frequent urination or urinary incontinence |
| 01/25/2001 | WO2001005790A1 New compounds |
| 01/25/2001 | WO2001005772A1 Pyrazinones, compositions containing such compounds |
| 01/25/2001 | WO2001005230A1 Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof |
| 01/25/2001 | WO2001005228A2 Fungicidal combinations of active substances |
| 01/25/2001 | DE19933938A1 Fungizide Wirkstoffkombinationen Fungicidal drug combinations |
| 01/25/2001 | CA2379577A1 Remedies or preventives for frequent urination or urinary incontinence |
| 01/25/2001 | CA2378202A1 New compounds |
| 01/25/2001 | CA2375954A1 Alpha-hydroxy-gamma-¬¬(carbocyclic-or heterocyclic-substituted)amino|carbonyl|alkanamide derivatives and uses thereof |
| 01/24/2001 | EP1070060A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists |
| 01/24/2001 | EP1069899A1 Treatment of panic attacks |
| 01/24/2001 | CN1281459A Piperidine derivatives |
| 01/24/2001 | CN1281439A 4-Hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 01/24/2001 | CN1280825A Sigma-receptor acting medicine containing protopine-type alkaloid |
| 01/23/2001 | US6177568 Intermediates for the synthesis of camptothecin derivatives |
| 01/23/2001 | US6177464 Bactericides |
| 01/23/2001 | US6177445 Substituted isoquinolines as ultra short acting neuromuscular blockers |
| 01/23/2001 | US6177440 Substituted tricyclics |
| 01/23/2001 | US6177439 Anticarcinogenic agents; viricides |
| 01/23/2001 | US6177423 N-(hydroxy or protected hydroxy)-benzo(de)isoquinoline-1,3-dione derivatives; bacterial dna gyrase and dna topoisomerase inhibitors useful for antibacterial agents having reduced drug resistance and reduced side effects |
| 01/23/2001 | US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
| 01/23/2001 | US6177379 Containing diels-alder adduct obtained by reacting specified azo compound and conjugated diene |
| 01/18/2001 | WO2001004122A2 New 2,3-benzodiazepine derivatives |
| 01/18/2001 | CA2378305A1 New 2,3-benzodiazepine derivatives |
| 01/17/2001 | EP1069127A1 Microencapsulated lewis acid |
| 01/17/2001 | EP1069125A2 Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments |
| 01/17/2001 | EP1069124A1 2-Benzimidazolylamine compounds as ORL1-receptor agonists |
| 01/17/2001 | EP1068189A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors |
| 01/17/2001 | EP0983258A4 N-hydroxy 4-sulfonyl butanamide compounds |
| 01/17/2001 | CN1280569A 1,2-dihydro-2-oxoquinoline derivatives |
| 01/17/2001 | CN1280567A Nitrogen-containing tetracyclic compounds |
| 01/16/2001 | US6174905 As carcinostatic agent to a hematologic malignancy and a solid carcinoma |
| 01/16/2001 | CA2314008A1 2-benzimidazolylamine compounds as orl1-receptor agonists |
| 01/11/2001 | WO2001002409A1 Thieno- and furopyrimidine derivatives as a2a-receptor antagonists |
| 01/11/2001 | WO2001002374A1 Bridged fluorescent dyes, their preparation and their use in assays |
| 01/11/2001 | WO2001002369A2 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 01/11/2001 | CA2376955A1 Bridged fluorescent dyes, their preparation and their use in assays |
| 01/10/2001 | EP1066258A1 Aryl phenyl substituted cyclic ketoenols |
| 01/10/2001 | EP1066039A1 Substituted quinazolines and analogs and the use thereof |
| 01/10/2001 | EP0777655B1 Process for preparing chiral tetracyclic dopaminergic compounds |
| 01/10/2001 | CN1279687A Bi-and tri-cyclic nucleoside, nucleotide and oligonucleotide analoguse |
| 01/10/2001 | CN1279682A bicyclic kinase inhibitors |
| 01/10/2001 | CN1279239A Acridine carboxylic ester compound, preparation and medicinal composition thereof |
| 01/10/2001 | CN1060478C Substituted pyrazole derivatives |
| 01/10/2001 | CN1060472C Hydroxamic acid derivatives with tricylic substitution, their preparing methods, medicines containing them and uses thereof |
| 01/09/2001 | US6172255 Alkoxy-alkyl-substituted 1-H-3-aryl-pyrrolidine-2,4-diones used as herbicides and pesticides |
| 01/09/2001 | US6172230 Process for the preparation of tetrahydro-indolizines |
| 01/09/2001 | US6172170 Initiators for radical polymerization |
| 01/09/2001 | US6172102 Pyrrole derivatives and medicinal composition |
| 01/09/2001 | US6172092 Fungicides, bactericides for crops; treating plant diseases; applying to wood, leather, plastic |
| 01/09/2001 | US6172084 Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| 01/09/2001 | US6172078 Quinolinomorphinane derivatives and medicinal use thereof |
| 01/09/2001 | US6172077 Tachykinin inhibitors; analgesics, antiinflammatory agents, antiemetics; neuralgia, headaches |
| 01/09/2001 | US6172074 Imidazopyridines and oxazolopyridines |
| 01/09/2001 | US6172073 Benzimidazolyloxy alkanamines as serotonin reuptake inhibitors; nicotine and tobacco withdrawal; psychological, eating, brain, gastrointestinal, sleep, and sexual disorders |
| 01/09/2001 | US6172006 Furyl-pyridone compounds, useful as fungicides and obtained from the fungus Cladobotryum |
| 01/04/2001 | WO2001000626A1 Hexahydropyrrolo[1,2-c]pyrimidines as antiviral, antifungal and/or antitumor agents |
| 01/04/2001 | WO2001000615A1 Respiratory syncytial virus replication inhibitors |
| 01/04/2001 | WO2001000213A1 Src kinase inhibitor compounds |